[登录] [免费注册]
试剂仪器网
位置:首页 > 资料中心 > 化工字典 > 130209-82-4
关键词:       仅模糊查询
CAS: 130209-82-4
分子式: C26H40O5
分子量: 432.59
英文名称: 
7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoic aci 1
(1R-(1-alpha(z),2-beta(r*),3-alpha,5-alpha))--methylethyl este
latanoprost
phxa 41
xa 41
xalatan
推荐供应商
货号品牌产品名称规格包装、参考价格
L838242MACKLIN拉坦前列腺素≥98%(HPLC), oil69元/5mg;   215元/25mg;   520元/100mg;   2289元/500mg;   咨询
储存:-20°C
状态:无色到淡黄色液体
L795448MACKLIN拉坦前列腺素10mM in DMSO657元/1ml;   咨询
储存:-20°C
L0262TCILatanoprost>98.0%(HPLC)490元/10MG;   1390元/50MG;   咨询

基本信息

纯度/分析方法>98.0%(HPLC)
分子式/分子量C26H40O5 = 432.60
外观与形状(20℃)液体
储存温度<0℃
应避免的情况加热
Reaxys-RN5912370
PubChem物质ID253662165
Merck Index (14)5376
MDL编号MFCD00216074

技术规格

AppearanceColorless to Light yellow clear liquid
Purity(HPLC)min. 98.0 area%
Specific rotation [a]20/D+33.0 to +36.0 deg(C=1, CHCl3)

物性(参考值)

闪点188 ℃
比旋光度 [α]D34° (C=1,CHCl3)
水溶性不溶
溶解性(易溶于)乙醇

安全信息

危险性说明H413 : 可能对水生生物造成长期持续有害影响。
防范说明P501 : 将内装物/容器送到批准的废物处理厂处理。
P273 : 避免释放到环境中。

相关法规

RTECS#MJ9669550
911174J&KLatanoprost96%, 一种前列腺素受体激动剂1045元/5MG;   1767元/10MG;   咨询

基本信息

分子式C26H40O5
分子量432.60
MDL编码MFCD00216074
存储条件Freezer -20℃

产品描述

Latanoprost是前列腺素F2α的类似物,是前列腺素类选择性FP受体的激动剂。Latanoprost增加葡萄膜巩膜外流,因而减少眼压。

靶点(IC50 & Targe)

prostanoid selective FP receptor

retinoid X receptor α

体外研究

Latanoprost是AMP激活蛋白激酶的间接激活剂,也是一个选择性PXRα拮抗剂[2]。Latanoprost在体外实验中诱导人类肾癌细胞(HCS)的形态异常和活力减弱、细胞周期阻滞。它还诱导了HCS细胞质膜的异常改变、DNA断裂、超微结构的异常以及Caspase的激活。Latanoprost破坏HCS细胞中MTP、减少脂肪生成、促进脂肪酸氧化、增强脂肪细胞和肌小管的GLUT4的转移和葡萄糖的吸收[2]。

体内研究

Latanoprost是一种用于治疗开角型青光眼和高眼压的临床用药。在两种Ⅱ型糖尿病小鼠模型中,能有效改善其葡萄糖和血脂异常。它能改善葡萄糖耐量。慢性给药可减少血脂、增强白色脂肪组织和骨骼肌中的胰岛素通路。Latanoprost能有效激活AMPK,调节糖尿病小鼠中的血糖血脂代谢相关基因[2]。

细胞实验

Cell lines: 人角膜基质细胞(HCS)

Concentrations: 50 mg/l-0.78125 mg/l

Incubation Time: 4, 8, 12 h

Method: 将HCS细胞接种于24孔板,用含10%的DMEM/F12培养基、置于37℃细胞培养箱进行培养。当细胞长至对数期时,将细胞培养基更换为含latanprost的培养基。按前所述条件继续培养,每4小时观察一次他们的形态变化及生长状态。

(Only for Reference)

动物实验

Animal Models: db/db 或 ob/ob 小鼠

Formulation: 0.5% Tween 80

Dosages: 10 或 40 mg/kg

Administration: 腹腔注射

(Only for Reference)

参考文献

[1] Shen JW, et al. Curr Eye Res. 2016, 17:1-8.

[2] Wang G, et al. Diabetologia. 2013, 56(12):2702-12.

[3] Richard L. Hébert, et al. The journal of biological chemistry. 2

安全信息

图形或危害标志
危险说明H302
H410
防范说明P264
P270
P273
P301+P312
P330
P391
P501
UN号码3077
危险分类9
包装等级III
C46666Alfa AesarLatanoprost4396元/25mg;   15890元/100mg;   咨询

基本信息

Ref#
46666

分子式
C26H40O5

分子量
315.47

GHS危害和防范说明

Hazard Statements
H301 H361

Precautionary Statements
P264 P301+P330+P331 P405 P201 P280 P308+P313

安全信息

危险等级
6.1

L1167Sigma-AldrichLatanoprost≥98% (HPLC)2069.62元/1 MG;   7180.23元/5 MG;   咨询

产品说明

应用

拉坦前列素已被用于:

  • 制备包含姜黄素纳米颗粒(CUR-NP)的热敏水凝胶,以确定其在氧化应激下对人小梁网(TM)细胞的治疗作用。
  • 作为酯类前药用于研究其对小鼠鼠眼表面的作用
  • 制备热敏水凝胶用于研究其对控制高眼压症的作用。

包装

1, 5 mg in glass bottle

生化/生理作用

拉坦前列素是一种强效、选择性前列腺素F2 α类似物受体激动剂。它在角膜中被酯酶水解为拉坦前列素酸的生物活性形式。拉坦前列素在降低眼内压(IOP)方面起一定作用,因此它具有治疗青光眼的疗效。

特点和优势

该化合物出现在《受体分类和信号转导手册》的 前列腺素类受体 页面。要浏览其他手册页, 单击此处 。
该化合物由 Johnson & Johnson 开发。如需浏览其他制药公司开发的化合物和批准的药物/候选药物列表,请点击此处。

基本信息

经验(实验)分子式C26H40O5
分子量432.59
MDL编号MFCD00216074
PubChem化学物质编号24724523
NACRESNA.77

产品性质

质量水平100
测定≥98% (HPLC)
形式oil
颜色 colorless to yellow
溶解性DMSO: freely soluble
methanol: soluble
创始人Johnson & Johnson
运输wet ice
储存温度−20℃
SMILES stringCC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2
InChI1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
InChI keyGGXICVAJURFBLW-CEYXHVGTSA-N
Gene Informationhuman ... PTGFR(5737)

安全信息

储存分类代码13 - Non Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
个人防护装备Eyeshields, Faceshields, Gloves, type N95 (US)
Y0002218LatanoprostCRS, European Pharmacopoeia (EP) Reference Standard16423.3元/ ;   咨询

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C26H40O5
分子量432.59
MDL编号MFCD00216074

产品性质

manufacturer/tradenameEDQM
储存温度−20℃
SMILES stringCC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2
InChI1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
InChI keyGGXICVAJURFBLW-CEYXHVGTSA-N

安全信息

储存分类代码10 - Combustible liquids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0002189Latanoprost for system suitabilityEuropean Pharmacopoeia (EP) Reference Standard16423.3元/ ;   咨询

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

包装

Unit quantity: 2 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C26H40O5
分子量432.59
MDL编号MFCD00216074

产品性质

储存温度−20℃
SMILES stringCC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2
InChI1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
InChI keyGGXICVAJURFBLW-CEYXHVGTSA-N

安全信息

储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
PHR1884SupelcoLatanoprostPharmaceutical Secondary Standard; Certified Reference Material8978.77元/50 MG;   咨询

产品说明

一般描述

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAB0500 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

基本信息

经验(实验)分子式C26H40O5
分子量432.59
MDL编号MFCD00216074

产品性质

质量水平300
等级certified reference material
pharmaceutical secondary standard
形式liquid
CofAcurrent certificate can be downloaded
包装pkg of 50 mg
药典可追溯性traceable to USP 1357475
储存温度-10 to -25℃
SMILES stringCC(C)OC(=O)CCC\C=C/C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc2ccccc2
InChI1S/C26H40O5/c1-19(2)31-26(30)13-9-4-3-8-12-22-23(25(29)18-24(22)28)17-16-21(27)15-14-20-10-6-5-7-11-20/h3,5-8,10-11,19,21-25,27-29H,4,9,12-18H2,1-2H3/b8-3-/t21-,22+,23+,24-,25+/m0/s1
InChI keyGGXICVAJURFBLW-CEYXHVGTSA-N

安全信息

储存分类代码10 - Combustible liquids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
CAS号首数字顺序排列: 1 2 3 4 5 6 7 8 9